Using miriti petiole to produce particleboards
نویسندگان
چکیده
This study aimed to use the petiole residues of miriti partially replace pine wood and evaluate effects this incorporation on physical mechanical properties particleboards. Panels were produced with 0, 25, 50, 75% in partial replacement 12% urea-formaldehyde adhesive. The chemical-physical showed potential particleboard production as they similar those pinewood. For properties, panels classified low density. There was an increase compression ratio and, consequently, hygroscopicity . it observed that modulus elasticity (MOE) rupture (MOR) did not show any statistical differences. perpendicular traction (PT), there a significant reduction 50%. Considering general analysis up 40% mirti can be substituted, situation meet mentioned CS-236-66, except for PT commercialization panels.
منابع مشابه
Using the BNC to produce
This paper describes an attempt to generate seemingly meaningful cryptic crossword clues without trying to analyse meaning but relying solely on word occurrence statistics. It is a continuation of a project in which I developed an application toolkit for cryptic crossword clue compilers. The software described here assembles simple cryptic clues using the resources developed in the earlier proj...
متن کاملNear Infrared Spectroscopy to Evaluate Composition of Agro-based Particleboards
Particleboards can be manufactured from particles of any lignin-cellulosic material that can be combined with an adhesive and consolidated under the action of temperature and pressure. Because the raw materials in the industrial process are continually changing, the particleboard industry requires methods for monitoring the quality of their products. Hence, the aim of this paper was to evaluate...
متن کاملUsing the Wittig reaction to produce alkenylcarbaboranes.
This communication reports the first use of the Wittig reaction to produce alkenylcarbaboranes.
متن کاملUsing glyco-engineering to produce therapeutic proteins.
INTRODUCTION Glycans are increasingly important in the development of new biopharmaceuticals with optimized efficacy, half-life, and antigenicity. Current expression platforms for recombinant glycoprotein therapeutics typically do not produce homogeneous glycans and frequently display non-human glycans which may cause unwanted side effects. To circumvent these issues, glyco-engineering has been...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ambiente Construído
سال: 2023
ISSN: ['1415-8876', '1678-8621']
DOI: https://doi.org/10.1590/s1678-86212023000200668